Michele T.
- Country
- Italy
- Department
- UOC Neurologia B
Research Overview
Data & Insights
Has run more than one trial at 0 of 1 partner site.
Specializations
Multiple Sclerosis and Demyelinating Disorders
The investigator concentrates on therapeutic strategies for multiple sclerosis and related inflammatory demyelination, addressing both relapsing and progressive disease courses.
- Relapsing‑remitting disease modulation
- Progressive disease neuroprotection
- Biomarker‑guided treatment selection
Research integrates immunomodulatory agents with neuro‑repair approaches to improve long‑term disability outcomes.
Cerebrovascular Disease and Stroke
Focused on acute and secondary prevention of ischemic stroke and high‑risk transient ischemic attacks, the work emphasizes vascular health and inflammation control.
- Early reperfusion therapies
- Anti‑inflammatory vascular protection
- Risk stratification for recurrent events
Efforts aim to reduce neurological sequelae and enhance functional recovery after cerebrovascular insult.
Epilepsy and Neurodevelopmental Disorders
Investigations target pharmacologic and device‑based interventions for refractory epilepsy, including genetic and developmental etiologies.
- Drug‑resistant focal seizures
- Genotype‑specific therapeutic pathways
- Neurostimulation techniques
The goal is to achieve seizure control while preserving cognitive development in pediatric and adult populations.
Neurodegenerative Movement Disorders
Therapeutic research encompasses disease‑modifying and symptomatic treatments for Parkinson’s disease and related motor fluctuation disorders.
- Motor fluctuation management
- Alpha‑synuclein targeting strategies
- Adjunctive non‑pharmacologic therapies
Emphasis is placed on preserving functional independence and quality of life for patients with progressive motor decline.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.